4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001450324-20-000004
Options or other derivatives
- CEO acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
EQUELS THOMAS K. · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-12 | Grant or award : show line 1 in the form Options | +300,000 | 300,000 | D |
Loading xslF345X03/primary_doc.xml…